Abstract
AimsThe immune checkpoint marker, Programmed cell death-ligand 1 (PD-L1), is expressed by both cancer epithelial cells and tumour-infiltrating immune cells (TICs) thus constituting a potential target for immunotherapy. This is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have